Trademark: 88461015
Word
ENACT
Status
Registered
Status Code
700
Status Date
Tuesday, December 8, 2020
Serial Number
88461015
Registration Number
6214070
Registration Date
Tuesday, December 8, 2020
Mark Type
4000
Filing Date
Wednesday, June 5, 2019
Published for Opposition
Tuesday, May 19, 2020

Trademark Owner History
MorphoSys AG - Original Registrant

Classifications
5 Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancer
42 Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological research, clinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncology

Trademark Events
Dec 8, 2020
Registered-Principal Register
Nov 3, 2020
1(B) Basis Deleted; Proceed To Registration
Sep 14, 2020
Notice Of Allowance Cancelled
Oct 27, 2020
Case Assigned To Intent To Use Paralegal
Sep 14, 2020
Teas Delete 1(B) Basis Received
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 9, 2020
Approved For Pub - Principal Register
Apr 9, 2020
Teas/Email Correspondence Entered
Apr 9, 2020
Correspondence Received In Law Office
Apr 9, 2020
Assigned To Lie
Apr 1, 2020
Teas Response To Suspension Inquiry Received
Mar 17, 2020
Notification Of Inquiry As To Suspension E-Mailed
Mar 17, 2020
Inquiry To Suspension E-Mailed
Mar 17, 2020
Suspension Inquiry Written
Sep 3, 2019
Notification Of Letter Of Suspension E-Mailed
Sep 3, 2019
Letter Of Suspension E-Mailed
Sep 3, 2019
Suspension Letter Written
Aug 26, 2019
Assigned To Examiner
Aug 21, 2019
Teas Amendment Entered Before Attorney Assigned
Aug 21, 2019
Teas Voluntary Amendment Received
Jun 19, 2019
New Application Office Supplied Data Entered In Tram
Jun 8, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24